Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A subpathway-based method of drug reposition for polycystic ovary syndrome.

Reproductive sciences (Thousand Oaks, Calif.) - 1 Apr 2015

Liu Hai-Ying, Liu Jian-Qiao, Mai Zi-Xin, Zeng Yan-Ting

Abstract excerpt

The need for development of new therapeutic agents for polycystic ovary syndrome (PCOS) is urgent due to general lack of efficient and specialized drugs currently available. We aimed to explore the metabolic mechanism of PCOS and inferred drug reposition for PCOS by a subpathway-based method. Using the GSE34526 microarray data from the Gene Expression Omnibus database, we first identified the differentially...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to Databases, Genetic
Share to Drug Repositioning

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Molecular Targeted Therapy

Share to Oligonucleotide Array Sequence Analysis

Share to Polycystic Ovary Syndrome

Share to Purines

Source

Open in PubMed Open full text

Identifiers

PMID: 25015903
DOI: 10.1177/1933719114542025
PMCID: PMC4812690

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A subpathway-based method of drug reposition for polycystic ovary syndrome.PMID 25015903Read ↗

Identification of the hub genes in polycystic ovary syndrome based on disease‐associated molecule networkSemantic proximity Read ↗

Integrative Multi-cohort Transcriptomics and Network Pharmacology Analysis Reveals Key Network Nodes and Potential Drug Clues in PCOS Granulosa CellsSemantic proximity Read ↗

Unraveling the complexity of the molecular pathways associated with polycystic ovary syndrome (PCOS) and identifying molecular targets for therapeutic development: a review of literatureSemantic proximity Read ↗

A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistanceSemantic proximity Read ↗

Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic moleculesSemantic proximity Read ↗

Gymnema sylvestre as a potential therapeutic agent for PCOS: insights from mRNA differential gene expression and molecular docking analysisSemantic proximity Read ↗

Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failureSemantic proximity Read ↗

Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disordersSemantic proximity Read ↗

Pharmacological mechanism of Xiaoyao San in the treatment of polycystic ovary syndrome based on network pharmacologySemantic proximity Read ↗

Systematic Investigation of the Potential Multi-Target Pharmacological Mechanisms of Astragaloside IV in Polycystic Ovary Syndrome via Network Pharmacology and In Vivo/In Vitro ExperimentsSemantic proximity Read ↗

Study on the Mechanisms and Experimental Verification of Cuscuta-Salvia (Tusizi-Danshen) in the Treatment of Polycystic Ovary Syndrome (PCOS) via Network PharmacologySemantic proximity Read ↗

Identification of Key Pathways and Genes in Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis and Prediction of Small Therapeutic MoleculesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.